Rat Anti-Mouse CD86/B702 Antibody (S-R434)
CD86,Cell surface antigen MAX.3,B7-2,B7.2,CD28LG2,Hly9-beta,Leukocyte differentiation antigen CD84,Signaling lymphocytic activation molecule 5,T-lymphocyte activation antigen CD86,Activation B7-2 antigen,B70,BU63,CTLA-4 counter-receptor B7.2,FUN-1
货号: S0B0827
- 价格: ¥260
- 规格:
- 数量:
产品介绍 评论(0)
宿主来源
Rat抗原名称
CD86/B7-2分子别名
T-lymphocyte activation antigen CD86, Activation B7-2 antigen, B70, BU63, CTLA-4 counter-receptor B7.2, FUN-1细胞定位
Cell membraneAccession
P42081克隆号
S-R434抗体类型
Mouse mAb抗体同种型
IgG2a,k应用
FCM反应种属 ?
Ms纯化方式
Protein G浓度
2 mg/ml标记
Unconjugated性状
Liquid缓冲体系
PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
储存条件
12 months from date of receipt / reconstitution, -20 °C as supplied
应用 | 稀释度 |
---|---|
FCM | 1:2000 |
CD86, also known as B7-2, is a crucial protein molecule in the immune system, belonging to the B7 protein family. This family comprises various costimulatory molecules that are essential for T-cell activation, proliferation, and the exertion of effector functions. CD86 provides the second signal (costimulatory signal) for T-cell activation by binding to the CD28 receptor on T-cells. This signal is necessary for the full activation and differentiation of T-cells into effector T-cells (e.g., Th1, Th2) or memory T-cells. CD86 also exerts a negative regulatory role through its interaction with the CTLA-4 receptor on T-cells. CTLA-4 has a higher affinity for CD86 than CD28, allowing it to competitively bind to CD86 during the later stages of T-cell activation, thereby inhibiting further T-cell activation and preventing excessive immune responses. CD86 also exerts a negative regulatory role through its interaction with the CTLA-4 receptor on T-cells. CTLA-4 has a higher affinity for CD86 than CD28, allowing it to competitively bind to CD86 during the later stages of T-cell activation, thereby inhibiting further T-cell activation and preventing excessive immune responses.
流式分析
Flow cytometric analysis of C57BL/6 mouse splenocytes treated with 500ng/ml LPS for 3 days, labelling CD86/B7-2 antibody at 1/2000 (0.1 μg) dilution (Right) compared with a Mouse monoclonal IgG isotype control (Left). Then cells were stained with CD19 - PE/Cy7 separately. Goat Anti - Mouse IgG Alexa Fluor® 647 was used as the secondary antibody. Gated on total viable cells.
评论(0)